AbbVie Inc. (ABBV) est une société cotée en bourse dans le Santé secteur, opérant dans le Drug Manufacturers - General secteur d'activité. Le siège social de l'entreprise est situé à North Chicago, IL, United States. Le PDG actuel est Scott T. Reents.
ABBV a date d'introduction en bourse 2013-01-02, 55,000 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $372.01B.
AbbVie Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a diverse portfolio of medicines across multiple therapeutic areas. The company's key products include HUMIRA for autoimmune diseases, SKYRIZI for psoriasis, RINVOQ for rheumatoid arthritis, IMBRUVICA and VENCLEXTA for blood cancers, and MAVYRET for hepatitis C, along with established brands such as Synthroid for hypothyroidism, Botox, Lupron, and Linzess for gastrointestinal conditions. AbbVie also offers specialized treatments in ophthalmology, neurology, and women's health, including eye care solutions and migraine therapies. Headquartered in North Chicago, Illinois, and incorporated in 2012, the company maintains research collaborations to advance its drug pipeline and expand its global reach.
